Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?

Trends in Immunology(2020)10.1016/j.it.2020.04.001Source: DataRank Database

Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome? is a research paper published in Trends in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 152 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access152 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 12.73)OA: hybridTopics (30)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Carlota Dobaño ORCID,Pierre Van Damme ORCID,Gemma Moncunill ORCID,Arnaud Marchant ORCID,Rym Ben Othman ORCID

Live enrichment

PubMed:32340868 PMC:PMC7142696 OpenAlex:https://openalex.org/W3015851459

Ministerio de Ciencia e InnovaciÃ³n

Grant: CEX2018-000806-S

NIAID NIH HHS

Grant: U19 AI118608

National Institutes of Health

Grant: 3U19AI118608-04S2

IMmunoPhenotyping Assessment of a Covid-19 Cohort (IMPACC): Clinical Site

European Commission

Grant: 305869

Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria

Department of Health, Australian Government

Generalitat de Catalunya

Canadian Child Health Clinician Scientist Program

FundaciÃ³n RamÃ³n Areces

Institut national de la recherche scientifique

BC Childrenâs Hospital Foundation

Michael Smith Foundation for Health Research

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Universiteit Antwerpen

FWCI

12.73

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S1471490620300661/pdf

publisherhttp://www.cell.com/article/S1471490620300661/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1471490620300661?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1471490620300661?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.it.2020.04.001

Fields of Study

Influenza Virus Research StudiesVaccine Coverage and HesitancySARS-CoV-2 and COVID-19 Research0301 basic medicine0303 health sciences03 medical and health sciencesHumansImmunity, ActiveVaccinationVaccines

MeSH Terms

HumansImmunity, ActiveVaccinationVaccines

Keywords

VaccinationBaseline (sea)Immune systemMedicineImmunologyImmunityBiologyAllergie et immunopathologieVaccinesArticleImmunitatImmunity, ActiveImmunologieHumansHuman medicineVacunació

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia

10.6084/m9.figshare.21128140.v1figshare

Additional file 1 of SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia

10.6084/m9.figshare.21128140figshare